文献速递糖尿病

血浆脂肪酸相关基因变异与2型糖尿病及血糖特征的孟德尔随机化研究

Association of genetic variants related to plasma fatty acids with type 2 diabetes mellitus and glycaemic traits: a Mendelian randomisation study.
PubMed 文献 · Diabetologia · 2019-11-05

本研究采用两样本孟德尔随机化方法,利用13个与十种脂肪酸相关的SNP作为工具变量,探讨血浆脂肪酸水平与2型糖尿病及血糖特征的因果关联。结果显示,十种脂肪酸中有八种的遗传易感性与2型糖尿病风险显著相关,且这些关联除棕榈油酸外均由FADS1/2基因变异驱动。

要点

  • 八种脂肪酸的遗传易感性与2型糖尿病风险显著相关。
  • α-亚麻酸、亚油酸、棕榈油酸和油酸与2型糖尿病风险降低相关。
  • 除棕榈油酸外,关联均由FADS1/2基因变异驱动。

核心结论

  • 十种脂肪酸中八种的遗传易感性与2型糖尿病、空腹血糖及胰岛β细胞功能相关。
  • 除棕榈油酸外,这些关联由FADS1/2基因变异驱动。

研究设计与样本

  • 两样本孟德尔随机化研究,选取13个与十种脂肪酸相关的SNP作为工具变量。
  • 2型糖尿病结局数据来自DIAGRAM联盟(898,130人),血糖特征数据来自MAGIC联盟(非糖尿病个体最多46,186人)。
  • 采用逆方差加权法进行分析。

主要发现

  • α-亚麻酸每增加1个SD,2型糖尿病OR为0.93(95%CI 0.90, 0.96;p=2.21×10^-5)。
  • 亚油酸每增加1个SD,OR为0.96(95%CI 0.94, 0.98;p=1.85×10^-4)。
  • 棕榈油酸每增加1个SD,OR为0.86(95%CI 0.81, 0.91;p=6.68×10^-7)。
  • 油酸每增加1个SD,OR为0.87(95%CI 0.81, 0.93;p=2.21×10^-5)。
  • 二十碳五烯酸每增加1个SD,OR为1.08(95%CI 1.03, 1.12;p=0.002)。

临床怎么用

  • 遗传学证据提示调节特定脂肪酸水平可能影响2型糖尿病风险及血糖特征。
  • FADS1/2基因变异在脂肪酸代谢与2型糖尿病关联中起关键作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Epidemiological data on the associations of circulating fatty acid levels with type 2 diabetes are inconsistent. We conducted a two-sample Mendelian randomisation study to explore the causal associations of plasma levels of ten fatty acids with type 2 diabetes and glycaemic traits. METHODS: Thirteen SNPs associated with circulating levels of ten individual fatty acids at the genome-wide significance level (p < 5 × 10-8) were selected as instrumental variables for the exposures. For the outcomes, summary-level data were obtained from the DIAbetes Genetics Replication And Meta-analysis (DIAGRAM) consortium for type 2 diabetes (898,130 individuals) and from the Meta-Analyses of Glucose and Insulin-related traits Consortium (MAGIC) for the glycaemic traits (up to 46,186 non-diabetic individuals). The inverse-variance weighted method was used for analyses. RESULTS: Genetic predisposition to higher plasma levels of eight of the ten fatty acids were statistically significantly associated with lower or higher odds of type 2 diabetes. The OR per one SD increment of each fatty acid was 0.93 (95% CI 0.90, 0.96; p = 2.21 × 10-5) for α-linolenic acid, 0.96 (95% CI 0.94, 0.98; p = 1.85 × 10-4) for linoleic acid, 0.86 (95% CI 0.81, 0.91; p = 6.68 × 10-7) for palmitoleic acid, 0.87 (95% CI 0.81, 0.93; p = 2.21 × 10-5) for oleic acid, 1.08 (95% CI 1.03, 1.12; p = 0.002) for eicosapentaenoic acid, 1.04 (95% CI 1.02, 1.07; p = 0.001) for docosapentaenoic acid, 1.03 (95% CI 1.02, 1.05; p = 2.51 × 10-5) for arachidonic acid and 1.09 (95% CI 1.03, 1.15; p = 0.003) for stearic acid. The same eight fatty acids were also associated with fasting glucose levels and HOMA-B. The associations, except that for palmitoleic acid, were driven by variants in FADS1/2. CONCLUSIONS/INTERPRETATION: Genetic predisposition to higher circulating levels of eight out of ten fatty acids was associated with type 2 diabetes, fasting glucose and islet beta cell function. However, the associations, except that for palmitoleic acid, were driven by variants in FADS1/2, which encode enzymes with a key role in fatty acid metabolism.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Yuan S, Larsson SC. Association of genetic variants related to plasma fatty acids with type 2 diabetes mellitus and glycaemic traits: a Mendelian randomisation study. Diabetologia. 2019. PMID: 31690987. doi:10.1007/s00125-019-05019-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。